Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Copa Corp, Net Income/Loss Unexpectedly Turn to Loss for Last Fiscal Year, The Current Fiscal Year's Net Income to Narrow
7689 Copa Corporation Inc. 【J-GAAP】
Earnings ReportCopa Corporation Inc. <7689> [TSE Growth] announced its financial results after the market closed on April 14th (15:30). The net loss (non-consolidated) for the fiscal year ending February 2025 was loss of 437 million yen, a reduction in the deficit compared to loss of 437 million yen in the previous term, falling below the forecast of a 1 million yen, and tuning into a loss. In the fiscal year ending February 2026, the loss is expected to further decrease to loss of 90 million yen. This will mark the fourth consecutive term of losses.
In the most recent three-month period, from December to February (4Q), the net loss expanded to a loss of 267 million yen (compared to a loss of 133 million yen in the same period last year). However, the operating profit/loss margin drastically improved from -33.8% in the same period last year to -26.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 2,572 | -116 | -117 | -133 | -45.0 | 0 | Apr 14, 2023 | J-GAAP |
Feb, 2024 | 2,205 | -371 | -371 | -1,281 | -432.6 | 0 | Apr 12, 2024 | J-GAAP |
Feb, 2025 | 2,052 | -281 | -278 | -437 | -147.8 | 0 | Apr 14, 2025 | J-GAAP |
YoY | -6.9% | +24.3% | +25.1% | +65.9% | +65.8% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2025 Guidance | 2,550 | 3 | 3 | 1 | 0.3 | 0 | Apr 12, 2024 | J-GAAP |
Feb, 2025 Results | 2,052 | -281 | -278 | -437 | -147.8 | 0 | Apr 14, 2025 | J-GAAP |
Revision Rate | -19.5% | - | - | - | - |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 1,266 | -64 | -61 | -61 | -20.9 | 0 | Oct 15, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | ー | ー | ー | ー | - | 0 | Apr 14, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 2,205 | -371 | -371 | -1,281 | -432.6 | 0 | Apr 12, 2024 | J-GAAP |
Feb, 2025 | 2,052 | -281 | -278 | -437 | -147.8 | 0 | Apr 14, 2025 | J-GAAP |
Feb, 2026 Guidance | 2,399 | -89 | -89 | -90 | -30.4 | 0 | Apr 14, 2025 | J-GAAP |
YoY | +16.9% | +68.3% | +68.0% | +79.4% | +79.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 364 | -123 | -121 | -133 | -44.9 | -33.8 | Apr 12, 2024 | J-GAAP |
Mar - May, 2024 | 474 | -45 | -45 | -45 | -15.5 | -9.5 | Jul 12, 2024 | J-GAAP |
Jun - Aug, 2024 | 792 | -19 | -16 | -16 | -5.5 | -2.4 | Oct 15, 2024 | J-GAAP |
Sep - Nov, 2024 | 379 | -108 | -109 | -109 | -36.9 | -28.5 | Jan 14, 2025 | J-GAAP |
Dec - Feb, 2024 | 407 | -109 | -108 | -267 | -90.3 | -26.8 | Apr 14, 2025 | J-GAAP |
YoY | +11.8% | +11.4% | +10.7% | -100.8% | -101.0% |
Related Articles
NISSO PRONITY, First Half Ordinary Profit Increases by 4%, Current Fiscal Year Dividend Revised Upward by 10 yen
Lacto Japan, Dec-Feb (1Q) Ordinary Profit Increases by 43%
SMN, Last Fiscal Year Net Income Revised Upward by 93%
DOUTOR NICHIRES, 12% Increase in Ordinary Profit, Record High for The First Time in Nine Years, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 4 yen
DEMAE-CAN, First Half Ordinary Profit Loss Narrows, Dec-Feb Ordinary Profit Loss Narrows
STUDIO ALICE, 6% Decrease in Ordinary Profit for The Current Fiscal Year
COSMOS Pharma, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 30%, Dec-Feb Ordinary Profit Increases by 40%
FP Partner, Dec-Feb (1Q) Ordinary Profit Decreases by 42%
DIP, 10% Decrease in Ordinary Profit for The Current Fiscal Year
Totenko, 2% Increase in Ordinary Profit for The Current Fiscal Year